VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $73,000 | -12.0% | 17,691 | 0.0% | 0.02% | -11.5% |
| Q1 2021 | $83,000 | -38.1% | 17,691 | -5.6% | 0.03% | -40.9% |
| Q4 2020 | $134,000 | -33.0% | 18,745 | 0.0% | 0.04% | -42.1% |
| Q3 2020 | $200,000 | +3.1% | 18,745 | +84.6% | 0.08% | +1.3% |
| Q1 2019 | $194,000 | +0.5% | 10,156 | -50.4% | 0.08% | -10.7% |
| Q4 2018 | $193,000 | -50.3% | 20,490 | 0.0% | 0.08% | -39.1% |
| Q3 2018 | $388,000 | -3.0% | 20,490 | 0.0% | 0.14% | 0.0% |
| Q2 2018 | $400,000 | – | 20,490 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |